Jade Biosciences JBIO 深 滬
等待開盤 08-21 09:30:00 美东时间
21.23
-1.320
-5.85%
華盛通- 最 高23.815
- 今 開23.815
- 成交量 93.66万股
- 最 低 20.70
- 昨 收 22.55
- 總市值 13.50亿
- 52周最高 28.00
- 市盈率 靜 --
- 換手率 1.47%
- 52周最低 6.91
- 委 比 9.09%
- 總股本 6359.74万
- 歷史最高 1050.525
- 量 比 0.99
- 振 幅 13.81%
- 歷史最低 -40.25
- 每 手 1
- 風險率 5.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $47
Wedbush analyst Laura Chico maintains Jade Biosciences (NASDAQ:JBIO) with a Outperform and raises the price target from $45 to $47.
08-11 21:40
Jade Biosciences Q2 EPS $(0.76) Misses $(0.64) Estimate
Jade Biosciences (NASDAQ:JBIO) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.64) by 18.75 percent. This is a 11.63 percent increase over losses of $(0.86) per share from the same period last year.
08-10 19:08
美股牛股 | 特朗普政府加码量子计算！QNT涨超13%；Backblaze涨超43%，与CoreWeave签署一项3.35亿美元协议
特朗普政府加码量子计算！ARQQ大涨超35%，QNT涨超13%；Backblaze涨超43%，与CoreWeave签署一项3.35亿美元的数据存储协议>>
06-24 15:51
美股大行评级 | 大摩再上调希捷科技和西部数据目标价；多家大行首予Lincoln买入评级
今日重点评级关注：HC Wainwright & Co.：维持Elicio Therapeutics"买入"评级，目标价从17美元升至23美元；Leerink Partners：维持SAB Biotherapeutics"跑赢大市"评级，目标价从7美元升至12美元
06-16 11:34
UBS Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $45
UBS analyst Michael Yee initiates coverage on Jade Biosciences (NASDAQ:JBIO) with a Buy rating and announces Price Target of $45.
06-15 20:55
Stock Market Today: S&P 500 Futures Fall, Dow Gains As House Challenges Trump's Military Authority—Broadcom, CrowdStrike, Lululemon In Focus
U.S. stock futures were mixed on Thursday, after a lower close on Wednesday, as the Nasdaq 100 and S&P 500 advanced, but the Dow Jones rose.
06-04 17:12
Reported Earlier, Jade Biosciences Prices $150M Stock Offering Of 10M Shares at $15 Each
Jade Biosciences, Inc. ("Jade" or the "Company") (NASDAQ:JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the pricing of a public
06-04 16:20
Ciena, Docusign And 3 Stocks To Watch Heading Into Thursday
Stocks to watch: CIEN, DOCU, LULU, report earnings today. MRAAF introduces world's first 100Vdc 2.2μF chip MLCC for auto safety.
06-04 13:24
Jade Biosciences Reveals Proposed Underwritten Public Offering; No Size Disclosed
Jade Biosciences, Inc. ("Jade" or the "Company") (NASDAQ:JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced that it intends to offer and
06-04 04:05
